Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit

GERMANTOWN, Md., Nov. 1, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., a China-based company focused on monoclonal antibody...

from PR Newswire: https://ift.tt/2N4Fm1A